Myhre syndrome is a rare genetic connective tissue disorder with multisystem involvement. One of at least four known mutations in the SMAD4 gene replaces an amino acid at protein position 496 or 500 with a different amino acid. Studies suggest that these mutations result in an abnormally stable SMAD4 protein that remains active in the cell longer than needed, enhancing the activity of the SMAD4 protein, which may result in abnormal transforming growth factor beta (TGF-β) signaling in many cell types, affecting development of several parts of the body.
Associated restrictive cardiomyopathy can be rapidly progressive. Laryngotracheal stenosis can cause life-threatening complications. The risk appears to increase with age and usually presents in adolescence or young adulthood.
Myhre syndrome
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
Q87.89 – Other specified congenital malformation syndromes, not elsewhere classified
SNOMEDCT:
699316006 – Myhre syndrome
Q87.89 – Other specified congenital malformation syndromes, not elsewhere classified
SNOMEDCT:
699316006 – Myhre syndrome
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:11/15/2021
Last Updated:01/19/2022
Last Updated:01/19/2022
Myhre syndrome